Tissue Repair Research

Pentosan Polysulfate (PPS)

FDA-approved product existsRecovery & tissue repairImmune & gut
4.7/10

BioHarmony verdict

Neutral

Pentosan polysulfate (oral Elmiron) is an FDA-approved sulfated polysaccharide drug for interstitial cystitis bladder pain, sometimes used off-label for joints. The benefit is modest and contested while it carries a dose-dependent retinal toxicity, with maculopathy risk reaching about 7-fold above 2,000 grams cumulative, per Tao 2025.

Read full report

What is Pentosan Polysulfate (PPS)?

Pentosan polysulfate is a prescription drug, sold as oral Elmiron for interstitial cystitis bladder pain, and it stands out in the repair world for one reason: it is actually FDA-approved with real trials behind it. It is a semi-synthetic sulfated polysaccharide, heparin-like in how it behaves, and that matters because it means this is a small-molecule-style drug, not a peptide. So even when people stack it for joints next to things like BPC-157 or TB-500, it does not belong in the same mechanism bucket as those peptides.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

Restores the bladder protective coating; in joints acts chondroprotective, anti-inflammatory, and clot-dissolving

Safety watch-outs

  • Any new blur, distortion, dark spots, or trouble reading: stop and see an ophthalmologist promptly, since this can signal pigmentary…
  • Unusual bleeding or bruising, blood in the stool, or black stools: stop and consult a clinician, since the drug is heparin-like.
  • Starting or already taking blood thinners or high-dose NSAIDs: do not combine without a clinician, because bleeding risk stacks.
  • Approaching long cumulative use over years: insist on regular retinal screening, since most maculopathy cases follow high cumulative dose.

Full risk profile in the BioHarmony report.

Dosing as published

Approved labelELMIRON prescribing information for interstitial cystitis
PopulationAdults covered by the approved ELMIRON indication
Dose100 mg three times daily (300 mg/day)
RouteOral capsule with water at least 1 hour before or 2 hours after meals
FrequencyThree times daily
DurationReassess after 3 months; the label permits another 3 months when improvement has not occurred and limiting adverse events are absent
PreparationReady-to-use 100 mg capsule; no reconstitution.
Source: Dosage and Administration; How Supplied

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingAn approved oral product exists; injectable joint products are not covered by that approval
Last checked2026-07-13
Next review2026-10-11

FDA-approved pentosan polysulfate sodium is marketed orally as Elmiron for relief of bladder pain or discomfort associated with interstitial cystitis. The label warns of retinal pigmentary changes with long-term use.

Primary sources

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
  4. 7.3/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedFDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.